Agf Management LTD Seagen Inc. Transaction History

Agf Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$191.51 - $216.16 $519,183 - $586,009	-2,711 Reduced 15.46%	14,821 $3.14 Million
Q2 2023 Aug 09, 2023	SELL	$187.64 - $206.25 $640,602 - $704,137	-3,414 Reduced 16.3%	17,532 $3.37 Million
Q1 2023 May 03, 2023	SELL	$127.59 - $203.08 $947,610 - $1.51 Million	-7,427 Reduced 26.18%	20,946 $4.24 Million
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $3.33 Million - $3.95 Million	28,373 New	28,373 $0

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Agf Management LTD, based on Form 13F filings with the SEC.

Stay updated on Agf Management LTD with notifications on news.